AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Jan 5, 2024
35599_dirs_2024-01-05_9e755879-575a-4e7b-bae4-ff3b4979a91b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-01-04
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-04 | Common shares | S | 15000 | $10.64 | Disposed | 134721 | Direct |
| 2024-01-05 | Common shares | S | 15000 | $10.41 | Disposed | 119721 | Direct |
Footnotes
F1: Represents shares sold pursuant to a 10b5-1 plan adopted on June 14, 2023.
F2: Represents shares sold pursuant to a 10b5-1 plan adopted on June 14, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20